|
Accidental fungus leads to promising cancer drug (Reuters, 6/29/08) |
|
|
|
|
June 29, 2008 |
|
A drug developed using nanotechnology and a fungus that
contaminated a lab experiment may be broadly effective against a range of
cancers, U.S. researchers reported on Sunday.
The drug, called lodamin, was improved in one of the last
experiments overseen by Dr. Judah Folkman, a cancer researcher who died in
January. Folkman pioneered the idea of angiogenesis therapy -- starving tumors
by preventing them from growing blood supplies.
…Efforts to improve it did not work well. Then Benny and
colleagues tried nanotechnology, attaching two "pom-pom"-shaped
polymers to TNP-470, protecting it from stomach acid.
Read the full article here.
|
|
Last Updated ( July 01, 2008 )
|
